In this issue:
Non-hormonal treatment of vasomotor symptoms from tamoxifen/aromatase inhibitor
ctDNA characterisation of invasive lobular carcinoma in metastatic breast cancer
Breast cancer diagnostic pathways across 10 international jurisdictions
Abemaciclib + endocrine therapy for hormone receptor+/HER2–/node+ high-risk early breast cancer
Eliminating breast surgery for invasive breast cancer after neoadjuvant systemic therapy
Plasmid DNA vaccine encoding HER2 ICD in advanced-stage HER2+ breast cancer
Trial for high-risk early breast cancer after neoadjuvant chemotherapy
Associations of physical activity/sedentary time with QOL/fatigue in new breast cancer
OS with adjuvant olaparib in BRCA1/2, high-risk early breast cancer
Oral SERD for hormone receptor+/HER2– advanced/metastatic breast cancer
Please login below to download this issue (PDF)